Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

Share Price is delayed by 15 minutes
Get Live Data
144.00    -1.00 (-0.69%)
Bid:
144.00
Ask:
145.00
Spread: 1.00 (0.694%)
Market Cap: £113.00m
XAR Live PriceLast checked at - London Stock Exchange

Intraday Xaar Share Chart

Trading Statement

20 Nov 2017 07:00

RNS Number : 9048W
Xaar PLC
20 November 2017
 

Xaar plc

 

Trading Update

 

Xaar plc ("Xaar"), a world leader in industrial inkjet technology, provides a trading update today.

 

Further to our interim results statement in September and our earlier trading update in July, in which we indicated that growth in revenues from new products was expected to be second half weighted, the board now expects that revenue in the second half year will be broadly in line with the first half. The shortfall against previous expectations results largely from fewer than planned new printer installs of Xaar's 2001 Printhead, and slower than anticipated ramp up of the Xaar 1201 Printhead due to supply constraints.

In ceramics, the printhead replacement business is now anticipated to represent c.70% of revenues in 2017. The new 1003 Printhead has performed strongly in this market but as competition for new printer installs continues to intensify, we have seen more limited success with the 2001 product.

Demand for the 1201 Printhead remains strong, but due to supply constraints, we have not been able to fulfil all of the demand this year. We expect supply will improve with new capacity coming on stream next year, and we continue to expect significant growth in 2018.

Although disappointed by the revenue shortfall on the underlying business, we are encouraged by our reducing dependence on our legacy ceramics business, where there is little visibility, and increasing competitive pressure. Our 2020 vision and commitment to delivering growth from new products in new markets is undiminished but the timing of ramp up of the range of new products we have introduced remains less predictable. In 2017 we expect that 80% of our underlying revenues will be from the seven new products introduced and new businesses acquired in the last two years. This progress, together with our previously announced increased investment in sales and marketing, supports our continuing transformation to a more diversified and customer-centric company.

 

Enquiries:

 

Xaar plc

 

Doug Edwards, Chief Executive Officer

Lily Liu, Chief Financial Officer

 

+44 (0)1223 423 663 

Tulchan Communications

James Macey White

David Ison

Deborah Roney

+44 (0)20 7353 4200

 

About Xaar

Xaar is a world-leader in the development of inkjet technology and manufacture of piezoelectric drop-on-demand industrial printheads. The company also develops and sells ink systems, electronics and fluid optimisation services to accelerate inkjet system development and adoption. Xaar printheads incorporate patented technology, which delivers unbeatable performance when decorating, patterning, depositing functional coatings on, or adding structure to, a variety of industrial and consumer products. Today leading manufacturers worldwide, in sectors ranging from ceramics, wide-format graphics and labels to direct-to-shape packaging and decorative laminates, choose Xaar's printheads because they are extremely precise, exceptionally versatile, incredibly reliable, and designed for high-volume production. Additional information about Xaar is available at www.xaar.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTVKLFFDFFZFBF
Date   Source Headline
26th Apr 20063:56 pmRNSDirector/PDMR Shareholding
24th Apr 20064:29 pmRNSResult of AGM
24th Apr 20067:01 amRNSAGM positive trading update
18th Apr 20066:05 pmRNSDirector/PDMR Shareholding
18th Apr 200611:31 amRNSAnnual Information Update
5th Apr 20064:59 pmRNSDirector/PDMR Shareholding
30th Mar 20065:24 pmRNSHolding(s) in Company
14th Mar 20066:21 pmRNSDirector/PDMR Shareholding
14th Mar 20067:01 amRNSFinal Results
21st Feb 20067:01 amRNSNotice of Preliminary Results
14th Feb 20065:29 pmRNSHolding(s) in Company
12th Jan 20067:00 amRNSPeriod-end trading update
29th Nov 20057:00 amRNSHolding(s) in Company
25th Nov 20051:02 pmRNSDirector/PDMR Shareholding
23rd Nov 20055:43 pmRNSDirector/PDMR Shareholding
22nd Nov 20056:30 pmRNSDirector/PDMR Shareholding
7th Nov 20057:00 amRNSAnalyst and investor seminar
3rd Nov 20056:17 pmRNSHolding(s) in Company
24th Oct 20054:13 pmRNSDirector/PDMR Shareholding
24th Oct 20054:11 pmRNSDirector/PDMR Shareholding
24th Oct 20052:47 pmRNSHolding(s) in Company
14th Oct 20056:13 pmRNSHolding(s) in Company
14th Oct 20056:05 pmRNSHolding(s) in Company
12th Oct 200512:44 pmRNSDirector/PDMR Shareholding
10th Oct 20055:22 pmRNSDirector/PDMR Shareholding
6th Oct 20057:00 amRNSHolding(s) in Company
5th Oct 200510:59 amRNSDirector/PDMR Shareholding
27th Sep 20056:11 pmRNSDirector/PDMR Shareholding
20th Sep 20051:06 pmRNSDirector/PDMR Shareholding
14th Sep 20057:02 amRNSAppointment of director
14th Sep 20057:01 amRNSInterim Results
12th Sep 20057:00 amRNSInvestment in trade partner
16th Aug 20055:51 pmRNSNotice of Interim Results
16th Aug 20052:30 pmRNSNotice of Interim Results
28th Jul 20054:32 pmRNSHolding(s) in Company
21st Jul 200510:28 amRNSHolding(s) in Company
6th Jul 20057:00 amRNSPositive half year update
4th Jul 200511:36 amRNSHolding(s) in Company
4th Jul 200511:26 amRNSDirector/PDMR Shareholding
8th Jun 20056:31 pmRNSHolding(s) in Company
2nd Jun 20054:05 pmRNSHolding(s) in Company
26th May 20054:22 pmRNSHolding(s) in Company
26th May 20052:15 pmRNSDirector Shareholding
20th May 20059:28 amRNSHolding(s) in Company
13th May 20057:01 amRNSSystems integration partner
5th May 20056:27 pmRNSHolding(s) in Company
29th Apr 200511:45 amRNSHolding(s) in Company
28th Apr 20052:30 pmRNSResult of AGM
28th Apr 20057:00 amRNSPositive AGM update
25th Apr 20055:10 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.